Suspected Legionella Transmission from a Single Donor to Two Lung Transplant Recipients - Pennsylvania, May 2022.


Journal

MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429

Informations de publication

Date de publication:
15 Sep 2023
Historique:
medline: 18 9 2023
pubmed: 14 9 2023
entrez: 14 9 2023
Statut: epublish

Résumé

In July 2022, the Pennsylvania Department of Health received two reports of laboratory-confirmed Legionnaires disease in patients who had recently received lung transplants from the same donor at a single Pennsylvania hospital. The donor's cause of death was freshwater drowning in a river, raising suspicion of potential donor-derived transmission, because Legionella bacteria naturally live in fresh water. Further investigation of patients receiving other organs from the same donor did not identify additional legionellosis cases. Health care-associated infection caused by water exposure at the hospital was also evaluated as a potential source of infection and was found to be unlikely. Hospital water quality parameter measurements collected during May-June 2022 were within expected ranges and no water disruptions were noted, although no testing for Legionella was performed during this period. Notifiable disease data did not identify any other Legionnaires disease cases with exposure to this hospital within the 6 months before or after the two cases. Although laboratory testing did not confirm the source of recipient infections, available data suggest that the most likely source was the donor lungs. This cluster highlights the need for increased clinical awareness of possible infection with Legionella in recipients of lungs from donors who drowned in fresh water before organ recovery.

Identifiants

pubmed: 37708069
doi: 10.15585/mmwr.mm7237a1
pmc: PMC10511268
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1001-1004

Déclaration de conflit d'intérêts

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Références

Surg Infect (Larchmt). 2012 Apr;13(2):114-20
pubmed: 22472003
Environ Sci Technol. 2022 Aug 16;56(16):11363-11373
pubmed: 35929739
Transpl Int. 2010 Jul;23(7):e32-4
pubmed: 20477998
Emerg Infect Dis. 2022 Mar;28(3):527-538
pubmed: 35195513
Am J Med. 1993 Jul;95(1):16-22
pubmed: 8328493
Microbiol Spectr. 2022 Jun 29;10(3):e0114021
pubmed: 35438512
Appl Environ Microbiol. 1981 Jan;41(1):9-16
pubmed: 7013702
Emerg Infect Dis. 2023 Jul;29(7):1455-1458
pubmed: 37279517

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH